Drug costs are are at an all-time high and most benefit plans aren’t built to absorb the blast. As specialty medications drive claims higher year after year, advisors need better strategies to help clients protect their plans and their people.
In this session, we’ll explore how to restructure plans, educate clients, and align funding models to support both access and sustainability.
We’ll cover:
● How to identify plans at risk of high drug cost exposure
● Options for plan restructuring to minimize impact
● Funding strategies that offer flexibility and protection
● Communicating drug cost realities without fear-mongering
● Q&A session
